investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

How do genome alterations cause human lung cancer?

Matthew L. Meyerson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Matthew L. Meyerson

Broad Institute

Cambridge, United States

Dana-Farber Cancer Institute

Boston, United States

Related projects

Pasi A Janne

Drug Resistance in Lung Cancer

Trachea, bronchus and lung

Guanghua Xiao

Integrative Analysis to Identify Therapeutic Targets for Lung Cancer

Trachea, bronchus and lung

Pathology

Pasi A Janne

Targeting ALK and ROS1 in Lung Cancer

Trachea, bronchus and lung

Michael J Eck

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Trachea, bronchus and lung

Jeffrey Gildersleeve

Serum Antibody Profiling with a Carbohydrate Microarray

Trachea, bronchus and lung

Pathology

Charles M. Rudin

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Trachea, bronchus and lung

David A Barbie

Targeting the cytokine circuitry of KRAS-driven lung cancer

Trachea, bronchus and lung

Mark Edward Hatley

Dissection of microRNA-21s role in non-small cell lung cancer

Trachea, bronchus and lung

Pediatric oncology or childhood cancer

Deborah Morrison

Role of Protein Scaffolds in RTK/Ras-Dependent Signal Transduction

Trachea, bronchus and lung